Patents by Inventor Christian Rudolph

Christian Rudolph has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9663769
    Abstract: The present disclosure provide novel variants of T7 RNA polymerase. Embodiments of T7 variants, according to the instant invention, include a Cysteine-Serine substitution on position 723 of the amino acid sequence of the T7 polypeptide. Embodiments of T7 variants according to the instant invention have a DNA-dependent RNA polymerase enzymatic activity and a reduced tendency to form intramolecular homodimers by way of oxidizing thiol groups. The amino acid substitutions within the T7 variants disclosed herein impact minimally, if at all, the RNA polymerase activity of the T7 polypeptide. Further, the mutations of the disclosed embodiments may optionally be combined with mutations which provide enhanced thermostability compared to the wild-type reference.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: May 30, 2017
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Michael Greif, Christian Rudolph, Manfred Schmidt, Harald Sobek, Johann-Peter Thalhofer
  • Patent number: 9319317
    Abstract: In a distributed switching environment, a plurality of switches are clustered together to form a stack, and it is generally desirable for forwarding tables, such as MAC tables, to be synchronized so that their mappings are consistent. When a switch receives a packet having a source address (e.g., MAC address) that is unknown, the switch is configured to disseminate the source address to the other switches of the stack. Rather than using software protocols to disseminate the source address, the switch instead transmits a multicast packet that (1) includes the unknown source address and (2) spoofs the other switches into believing that the packet was received on the same port from which the unknown source address was received on ingress to the stack. Thus, the other switches learn the unknown source address in hardware without having to rely on software for updating their forwarding tables.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: April 19, 2016
    Assignee: ADTRAN, Inc.
    Inventors: Derek Martin Spadaro, Mark Christian Rudolph, Timothy James Schlichter
  • Publication number: 20160032260
    Abstract: The present invention provides improved variants of T7 RNA polymerase by introducing novel mutations which lead to improved thermostability of the enzyme. According to the invention, amino acid substitutions at the positions Val426, Ser633, Val650, Thr654, Ala702, Val795, and combinations thereof are advantageous.
    Type: Application
    Filed: October 16, 2015
    Publication date: February 4, 2016
    Inventors: Harald Sobek, Johann-Peter Thalhofer, Rainer Mueller, Manfred Schmidt, Michael Greif, Armin Ruf, Christian Rudolph
  • Publication number: 20160032261
    Abstract: The present invention provides improved variants of T7 RNA polymerase by introducing novel mutations which lead to improved thermostability of the enzyme. According to the invention, amino acid substitutions at the positions Val426, Ser633, Val650, Thr654, Ala702, Val795, and combinations thereof are advantageous.
    Type: Application
    Filed: October 16, 2015
    Publication date: February 4, 2016
    Inventors: Harald Sobek, Johann-Peter Thalhofer, Rainer Mueller, Manfred Schmidt, Michael Greif, Armin Ruf, Christian Rudolph
  • Publication number: 20160010069
    Abstract: The present disclosure provide novel variants of T7 RNA polymerase. Embodiments of T7 variants, according to the instant invention, include a Cysteine-Serine substitution on position 723 of the amino acid sequence of the T7 polypeptide. Embodiments of T7 variants according to the instant invention have a DNA-dependent RNA polymerase enzymatic activity and a reduced tendency to form intramolecular homodimers by way of oxidizing thiol groups. The amino acid substitutions within the T7 variants disclosed herein impact minimally, if at all, the RNA polymerase activity of the T7 polypeptide. Further, the mutations of the disclosed embodiments may optionally be combined with mutations which provide enhanced thermostability compared to the wild-type reference.
    Type: Application
    Filed: October 1, 2015
    Publication date: January 14, 2016
    Inventors: Michael Greif, Christian Rudolph, Manfred Schmidt, Harald Sobek, Johann-Peter Thalhofer
  • Patent number: 9193959
    Abstract: The present invention provides improved variants of T7 RNA polymerase by introducing novel mutations which lead to improved thermostability of the enzyme. According to the invention, amino acid substitutions at the positions Val426, Ser633, Val650, Thr654, Ala702, Val795, and combinations thereof are advantageous.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: November 24, 2015
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Harald Sobek, Johann-Peter Thalhofer, Rainer Mueller, Manfred Schmidt, Michael Greif, Armin Ruf, Christian Rudolph
  • Publication number: 20120252071
    Abstract: The present disclosure provide novel variants of T7 RNA polymerase. Embodiments of T7 variants, according to the instant invention, include a Cysteine-Serine substitution on position 723 of the amino acid sequence of the T7 polypeptide. Embodiments of T7 variants according to the instant invention have a DNA-dependent RNA polymerase enzymatic activity and a reduced tendency to form intramolecular homodimers by way of oxidizing thiol groups. The amino acid substitutions within the T7 variants disclosed herein impact minimally, if at all, the RNA polymerase activity of the T7 polypeptide. Further, the mutations of the disclosed embodiments may optionally be combined with mutations which provide enhanced thermostability compared to the wild-type reference.
    Type: Application
    Filed: March 30, 2012
    Publication date: October 4, 2012
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Michael Greif, Christian Rudolph, Manfred Schmidt, Harald Sobek, Johann-Peter Thalhofer
  • Publication number: 20110256589
    Abstract: The present invention provides improved variants of T7 RNA polymerase by introducing novel mutations which lead to improved thermostability of the enzyme. According to the invention, amino acid substitutions at the positions Val426, Ser633, Val650, Thr654, Ala702, Val795, and combinations thereof are advantageous.
    Type: Application
    Filed: March 23, 2011
    Publication date: October 20, 2011
    Inventors: Harald Sobek, Johann-Peter Thalhofer, Rainer Mueller, Manfred Schmidt, Michael Greif, Armin Ruf, Christian Rudolph
  • Patent number: D710131
    Type: Grant
    Filed: January 15, 2013
    Date of Patent: August 5, 2014
    Assignee: McNett Corporation
    Inventors: Duane V. McNett, Travis Huisman, Aaron McElroy, Geoff Perrin, Christian Rudolph
  • Patent number: D713657
    Type: Grant
    Filed: January 15, 2013
    Date of Patent: September 23, 2014
    Assignee: McNett Corporation
    Inventors: Duane V. McNett, Travis Huisman, Christian Rudolph, Aaron McElroy, Geoff Perrin, Tanya Brooks